XML 28 R14.htm IDEA: XBRL DOCUMENT v3.19.2
Note 9 - Income Taxes
6 Months Ended
Jun. 30, 2019
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
NOTE
9:
INCOME TAXES
 
On
December 22, 2017,
the Tax Cuts and Jobs Act was enacted in the U.S. Tax Reform significantly lowering the amount of current and future income tax expense primarily due to the reduction in the U.S. statutory tax rate from
35.0%
to
21.0%.
This provision went into effect on
January 1, 2018
and resulted in the loss of our ability to take the domestic production activities deduction which has been repealed and requires us to remeasure our deferred tax assets and liabilities.
 
The provision for income taxes includes the following:
 
   
Six Months Ended June 30,
 
   
2019
   
2018
 
Current:
               
Federal
  $
---
    $
48,330
 
State
   
7,303
     
3,500
 
Total current provision
   
7,303
     
51,830
 
Deferred:
               
Federal
  $
(698,000
)   $
56,888
 
State
   
------
     
----
 
Total deferred (benefit) provision
   
(698,000
)    
56,888
 
Income tax expense (benefit) provision
  $
(690,697
)   $
108,718
 
 
 
Tax Rate Reconciliation
 
The reconciliation between the Company’s effective tax rate on income from continuing operations and the statutory rate is as follows:
 
   
Six Months Ended
 
   
June 30,
 
   
2019
   
2018
 
Income tax provision at federal statutory rate (21%)
  $
(895,428
)   $
(139,314
)
Foreign tax loss
   
28,175
     
82,715
 
State taxes
   
3,000
     
3,500
 
Difference between tax and book depreciation
   
48,144
     
39,827
 
Stock compensation
   
62,505
     
140,052
 
Other Permanent differences
   
62,907
     
(18,062
)
Income tax (benefit) expense
  $
(690,697
)   $
108,718
 
 
The Company’s foreign subsidiary, CVD Tantaline ApS incurred a loss of approximately
$134,000
for the
six
months ended
June 30, 2019
which would provide a
$28,000
deferred tax asset, based on the standard corporate tax rate of
22%
in Denmark. For the
six
months ended
June
31,
2018
the Company had a loss of
$394,000
with a deferred tax asset of
$83,000.
However, sufficient uncertainty exists as to the realizability of these assets such that a full valuation allowance has been necessary.
 
We continue to evaluate for potential utilization of the Company’s deferred tax asset on a quarterly basis, reviewing our economic models, including projections and timing of orders, the commencement of operations of the new CVD Materials segment and cost containment measures.